https://www.marketscreener.com/quote/stock/IPSEN-5137/news/Exelixis-and-Ipsen-Announce-Positive-Results-from-Phase-3-CONTACT-02-Pivotal-Trial-Evaluating-Caboza-44657672/?utm_source=telegram&utm_medium=social&utm_campaign=share